Skip to content
Search

Latest Stories

RSV vaccination pilot to expand to 200 pharmacies in 2025/26

CCA estimates that allowing pharmacies to deliver RSV, pneumonia, shingles, meningitis, and routine childhood vaccinations could free up 10 million GP appointments each year.

NHS to roll out RSV vaccinations across 200 pharmacies in 2025/26

NHS England aims to ensure that everyone aged 75 to 79 years old is offered RSV vaccination by 31 August 2025.

Photo credit: gettyimages

As part of its public health functions for 2025/26, NHS England plans to expand the Respiratory Syncytial Virus (RSV) immunisation programme to include up to 200 community pharmacies in targeted areas.

This follows the launch of an early adopter initiative in September 2024, where 50 community pharmacy sites in the East of England were commissioned to offer RSV vaccinations.


Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA), welcomed the expansion and urged the NHS to accelerate the rollout across more pharmacy sites.

“Pharmacies can increase access and convenience for patients so they can receive vaccines when and where they want them,” he said.

Harrison pointed out community pharmacies’ excellent track record of administering the flu and Covid-19 vaccines.

“Pharmacies have delivered over a quarter of Covid-19 vaccines to date, and increased patient access, particularly for underserved communities,” he said.

He further advocated for pharmacies to be commissioned to deliver a a wider range of NHS vaccines nationally—including RSV, pneumonia, shingles, meningitis, and routine childhood immunisations

“Taken together, we estimate that this could free up 10 million GP appointments each year,” he said.

“Alongside existing pharmaceutical services, this expansion would increase access and give patients greater choice.”

“This is especially important as vaccine uptake remains a concern, especially amongst underserved and vaccine-hesitant cohorts,” he added.

Under the updated public health functions agreement, NHS England aims to ensure that everyone aged 75 to 79 years old on 1 September 2024 is offered RSV vaccination by 31 August 2025.

It will also continue the ongoing catch-up and year-round RSV programme offer for those turning 75 years old and pregnant women (from 28 weeks).

The agreement outlines how the Secretary of State for Health and Social Care delegates responsibility for certain public health functions to NHS England. These include:

NHS England has been delegated responsibility for securing the provision of the following services:

  • National immunisation programmes
  • Population and targeted screening programmes
  • Public health services for children and adults in secure and detained settings
  • Sexual assault services
  • Child health information services

This is in addition to NHS England’s health service functions under the National Health Service Act 2006.

This agreement aims to improve population health outcomes and reduce health inequalities by continuously developing and delivering these services.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less